Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Non-cash Items: 2017-2024

Historic Non-cash Items for Rhythm Pharmaceuticals (RYTM) over the last 7 years, with Dec 2024 value amounting to $4.6 million.

  • Rhythm Pharmaceuticals' Non-cash Items rose 16.33% to $4.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.6 million, marking a year-over-year increase of 16.33%. This contributed to the annual value of $4.6 million for FY2024, which is 16.33% up from last year.
  • Rhythm Pharmaceuticals' Non-cash Items amounted to $4.6 million in FY2024, which was up 16.33% from $3.9 million recorded in FY2023.
  • Over the past 5 years, Rhythm Pharmaceuticals' Non-cash Items peaked at $4.6 million during FY2024, and registered a low of $3.1 million during FY2022.
  • Its 3-year average for Non-cash Items is $3.9 million, with a median of $3.9 million in 2023.
  • Its Non-cash Items has fluctuated over the past 5 years, first dropped by 3.77% in 2022, then climbed by 27.27% in 2023.
  • Over the past 4 years, Rhythm Pharmaceuticals' Non-cash Items (Yearly) stood at $3.2 million in 2021, then declined by 3.77% to $3.1 million in 2022, then rose by 27.27% to $3.9 million in 2023, then increased by 16.33% to $4.6 million in 2024.